Published in J Natl Cancer Inst on October 01, 1968
Sizes and concentrations of several type C oncornaviruses and bacteriophage T2 by the resistive-pulse technique. J Virol (1977) 1.03
Characteristics of a virus isolated from a feline fibrosarcoma. J Virol (1970) 0.95
The association of viruses with urveal melanoma. Trans Am Ophthalmol Soc (1979) 0.80
Theta particles: a structure found in hamster sarcoma virus. J Virol (1972) 0.75
Distribution of C-type viral particles in a spontaneous case of lymphatic leukemia in a cat. Can Vet J (1969) 0.75
Immune reactions in mucous membranes. I. Intestinal mast cell response during helminth expulsion in the rat. Immunology (1971) 2.78
Production of diarrhoea and dysentery in pigs by feeding pure cultures of a spirochaete differing from Treponema hyodysenteriae. Vet Rec (1980) 2.35
High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papilloma virus. Nature (1978) 2.29
Quantitative studies on the kinetics of establishment and expulsion of intestinal nematode populations in susceptible and immune hosts. Nippostrongylus brasiliensis in the rat. Parasitology (1968) 2.25
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Neoplastic diseases of the haematopoietic and lymphoid tissues. Bull World Health Organ (1974) 2.14
Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet Rec (2001) 2.08
Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst (1973) 2.00
The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer (1978) 1.66
Determinants of the host range of feline leukaemia viruses. J Gen Virol (1973) 1.64
Biology of feline leukemia virus in the natural environment. Cancer Res (1976) 1.59
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology (1995) 1.48
Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med (1995) 1.46
Mast cells and macromolecular leak in intestinal immunological reactions. The influence of sex of rats infected with Nippostrongylus brasiliensis. Immunology (1971) 1.46
Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J Immunol (1983) 1.44
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43
Vaccination against feline leukaemia virus. Vet Rec (1994) 1.39
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Persistence of non-integrated viral DNA in bovine cells transformed in vitro by bovine papillomavirus type 2. Nature (1981) 1.35
Replication of cat leukemia virus in cell cultures. Nature (1968) 1.34
Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol (1992) 1.33
Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS (1991) 1.33
A British abattoir survey of tumours in cattle, sheep and pigs. Vet Rec (1969) 1.28
Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J Gen Virol (1993) 1.26
Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. J Natl Cancer Inst (1971) 1.25
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology (1991) 1.25
Isolation of the nucleic acid of feline leukemia virus. Virology (1971) 1.25
A study of naturally occurring feline coronavirus infections in kittens. Vet Rec (1992) 1.24
Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J Immunol (1985) 1.22
Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B. Int J Cancer (1978) 1.21
A field study of parasitic gastritis in cattle. Vet Rec (1965) 1.21
Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology (1993) 1.17
A new papillomavirus associated with alimentary cancer in cattle. Nature (1980) 1.16
A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J Virol (1993) 1.15
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Vet Rec (1990) 1.15
Unintegrated viral DNA sequences in a hamster tumor induced by bovine papilloma virus. J Virol (1981) 1.14
Serological responses of cats to feline immunodeficiency virus. AIDS (1990) 1.14
Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. Virology (1981) 1.13
Immunological unresponsiveness in adult rats to the nematode Nippostrongylus brasiliensis induced by infection in early life. Nature (1966) 1.12
Selective effect of feline leukaemia virus on early erythroid precursors. Nature (1982) 1.12
Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol (1995) 1.11
Virus-induced papillomas of the alimentary tract of cattle. Int J Cancer (1978) 1.11
Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet Rec (1990) 1.11
Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia. Int J Cancer (1984) 1.10
Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology (1994) 1.09
Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis (1994) 1.09
Immunological unresponsiveness to helminth parasites. I. The pattern of Nippostrongylus brasiliensis infection in young rats. Exp Parasitol (1968) 1.09
Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet Rec (2001) 1.09
Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS (1991) 1.08
Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J Gen Virol (1994) 1.06
Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Res (1992) 1.06
Viral oncogenesis: lessons from naturally occurring animal viruses. Cancer Surv (1987) 1.05
Vaccination against feline leukaemia virus using a cell membrane antigen system. Int J Cancer (1975) 1.04
Lymphosarcoma (leukemia) in cattle, sheep and pigs in Great Britain. Cancer (1968) 1.03
Anemia associated with feline leukemia virus infection in cats. J Natl Cancer Inst (1975) 1.03
Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol (1992) 1.03
5-hydroxytryptamine in intestinal immunological reactions. Its relationship to mast cell activity and worm expulsion in rats infected with Nippostrongylus brasiliensis. Int Arch Allergy Appl Immunol (1971) 1.02
Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Int J Cancer (1977) 1.02
Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. J Virol (1993) 1.01
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol (1998) 1.01
Isolation of parainfluenza virus SV5 from dogs with respiratory disease. Vet Rec (1976) 1.01
Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J Immunol (1996) 1.00
Detection of transient and persistent feline leukaemia virus infections. Vet Rec (1982) 1.00
A comparison of DNA amplification, isolation and serology for the detection of Chlamydia psittaci infection in cats. Vet Rec (1998) 1.00
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J Virol (1996) 0.99
Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases. J Natl Cancer Inst (1975) 0.99
Clinical and pathological findings in feline immunodeficiency virus experimental infection. Vet Immunol Immunopathol (1992) 0.99
Polypeptides of feline leukemia virus: a glycosylated gag-related protein is released into culture fluids. Virology (1980) 0.98
A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology (1984) 0.98
Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Vet Rec (2000) 0.98
Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet Pathol (1996) 0.98
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol (2000) 0.95
Feline viruses in wildcats from Scotland. J Wildl Dis (1999) 0.95
Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res Hum Retroviruses (1995) 0.94
Immunity to Haemonchus contortus infection: relationship between age and successful vaccination with irradiated larvae. Am J Vet Res (1966) 0.94
Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine (1996) 0.94
Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol (2001) 0.93
Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. Immunology (1995) 0.92
Feline leukaemia virus proviral DNA detected by polymerase chain reaction in antigenaemic but non-viraemic ('discordant') cats. Arch Virol (1997) 0.92
Antibodies in normal and leukemic cats to feline oncornavirus-associated cell membrane antigens. J Natl Cancer Inst (1973) 0.92
Feline leukemia. Int Rev Exp Pathol (1971) 0.92
Lymphosarcoma in experimentally induced feline immunodeficiency virus infection [corrected]. Vet Rec (1992) 0.92
Growth of feline leukaemia virus in human cells. Nature (1969) 0.91
Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Vet Rec (1997) 0.91
Membranous glomerulonephritis associated with leukaemia in cats. Res Vet Sci (1971) 0.91
Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes. Immunology (2000) 0.90
A comparison of three methods of feline leukaemia virus diagnosis. Vet Rec (1982) 0.90